Publications by authors named "Disha Rao"

Claim this Profile
I
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.
Elisa A Rozeman, Judith M Versluis, Karolina Sikorska, Esmée P Hoefsmit, Petros Dimitriadis, Disha Rao

J Immunother Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acidity-mediated induction of FoxP3 regulatory T cells.
Disha Rao, Johanna A Stunnenberg, Ruben Lacroix, Petros Dimitriadis, Joanna Kaplon

Eur J Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.
Irene L M Reijers, Disha Rao, Judith M Versluis, Alexander M Menzies, Petros Dimitriadis

J Exp Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells.
Esmée P Hoefsmit, Paula T van Royen, Disha Rao, Johanna A Stunnenberg, P Dimitriadis

Cancer Immunol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MeVa2.1.dOVA and MeVa2.2.dOVA: two novel BRAFV600E-driven mouse melanoma cell lines to study tumor immune resistance.
Disha Rao, Ruben Lacroix, Alex Rooker, Tainá Gomes, Johanna A Stunnenberg

Melanoma Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic profiles of regulatory T cells in the tumour microenvironment.
Disha Rao, Fabienne Verburg, Kathrin Renner, Daniel S Peeper, Ruben Lacroix

Cancer Immunol Immunother· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells and tertiary lymphoid structures promote immunotherapy response.
Beth A Helmink, Sangeetha M Reddy, Jianjun Gao, Shaojun Zhang, Rafet Basar, Disha Rao

Nature· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis